(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEWOMICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NEWOMICS

ST13

US500000086939458

Class

10, 42, 44

Filing

86939458

Registration

5571018

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

48

Latest update

04/19/2024

Trademark type

Word

Nice classes

10, 42, 44

Filing date

03/14/2016

Registration date

09/25/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/19/2024

Last transaction

04/19/2024

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/04/2017

First use in commerce

06/04/2017

Drawing code

4

Owner type

03

Owner location

Berkeley, CA, US

Examiner

RUTLAND, BARBARA A

Law office

L10

Current location

TMEG LAW OFFICE 101

Holders and representatives

Holders

Newomics Inc.
Newomics Inc.

Representatives

Newomics Inc.

Technical classification

Nice Classes

Class 10Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometershematology analyzerssample preparation devicerelated data management software sold as a unit; Medical treatment apparel; Medical devicesminimally invasive neurovascular devices for the treatment of neurological conditions; Medical instrument for cardiovascular diagnostics; Sample preparation device for medical diagnostic uses

Class 42

Medical and scientific research in the field of cancer treatment and diagnosis; Pharmaceutical drug development services

Class 44

Medical testing for diagnostic or treatment purposes; Medical diagnosis and treatment of human diseasesinfectiousneurologicalcardiovascularcancerous and inflammatory diseases; Medical diagnosis of human diseasesinfectiousneurologicalcardiovascularcancerous and inflammatory diseases; Medicalphysical rehabilitation and physical therapy services; Performing diagnosis of diseases

Publications

History of USPTO decisions and trademark events.

48 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

04/19/2024

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

04/19/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/16/2024

ES8R

TEAS SECTION 8 RECEIVED

01/13/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/25/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

09/25/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/24/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/23/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

08/23/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/23/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

08/23/2018

SNEA

SU-EXAMINER'S AMENDMENT WRITTEN

08/23/2018

RDX3

NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED

01/08/2018

RDX1

ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED

01/08/2018

RRDX

ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED

01/08/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/12/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/12/2017

ALIE

ASSIGNED TO LIE

12/11/2017

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

12/04/2017

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

12/04/2017

GNFR

FINAL REFUSAL E-MAILED

12/04/2017

CNFR

SU - FINAL REFUSAL - WRITTEN

12/04/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/08/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/07/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/07/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/25/2017

GNRT

NON-FINAL ACTION E-MAILED

10/25/2017

CNRT

SU - NON-FINAL ACTION - WRITTEN

10/25/2017

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/02/2017

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/28/2017

IUAF

USE AMENDMENT FILED

09/18/2017

EISU

TEAS STATEMENT OF USE RECEIVED

09/18/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/25/2017

EX1G

SOU EXTENSION 1 GRANTED

03/23/2017

EXT1

SOU EXTENSION 1 FILED

03/23/2017

EEXT

SOU TEAS EXTENSION RECEIVED

03/23/2017

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/27/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/02/2016

PUBO

PUBLISHED FOR OPPOSITION

08/02/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/13/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/25/2016

XAEC

EXAMINER'S AMENDMENT ENTERED

06/24/2016

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/24/2016

GNEA

EXAMINERS AMENDMENT E-MAILED

06/24/2016

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/24/2016

DOCK

ASSIGNED TO EXAMINER

06/23/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/17/2016

NWAP

NEW APPLICATION ENTERED

03/17/2016

Continuous trademark protection

Get notified about every new filing that threatens NEWOMICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.